GAST and stage 5 chronic kidney disease: End-stage renal disease (ESRD) patients have higher than normal circulating levels of gastrin, probably due to decreased renal clearance of gastrin, increased gastric G cell density, and decreased inhibition secondary to diminished somatostatin levels [35].